Abbott’s continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. The system tracks glucose in real time, giving users insights and coaching to improve overall health. This move aligns with a trend of health companies developing innovative technologies, such as Abbott’s Vertigo Coach app and CardioMEMS implantable cardiac sensor system. Other players in the glucose monitoring space include Dexcom’s Stelo and Medtronic’s Guardian Connect and Guardian Sensor 3. Abbott’s imaging software Ultreon 1.0 Software uses AI to provide clearer images of heart vessels. Overall, these advancements aim to empower individuals to take control of their health and wellness.
Source link
Abbott’s Lingo glucose monitoring system available in the U.S.
